It is available in injectable and sublingual form and is used off-label for muscle improvements and anti-aging purposes
Disruption of the gut microbiome (dysbiosis) leads to increased inflammation and dysfunction of the glymphatic system, resulting in the accumulation of toxic proteins and decreased cognitive function
Yoon KH, Kang J, Kwon SC, Trautmann ME, Hompesch M, Stewart J, Sorli CH (2020) Pharmacokinetic and dose-finding studies on efpeglenatide in patients with type 2 diabetes
no enrollment or membership fee per published terms 6-month offer: Commercial satisfaction policy with specific adherence and documentation requirements - not a medical guarantee of weight loss results Eligibility (brand-stated): BMI 30, or BMI 27 with a qualifying comorbidity (type 2 diabetes, hypertension, dyslipidemia, sleep apnea, cardiovascular disease)
Current motors primarily focus on drug delivery
Media Contact Eric Savitch SVP and Group Brand Director EnsembleIQ [email protected]